[JSMN]

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [Special Program]JSNM Symposium

JSNM Symposium 9
Current status and future perspective of radiopharmaceutical development oriented toward Radio-theranostics

Fri. Nov 16, 2018 1:30 PM - 3:30 PM Room5 (Conference Building B 1F B2)

Chair:Yuji Kuge (Central Institute of Isotope science, Hokkaido University), Yasushi Kiyono (Biomedical Imaging Research Center, University of Fukui)

+Add all to schedule

[JSNMS9-1] 1．Development of meta-[ ²¹¹At]astatobenzylguanidine: basic study with pheochromocytoma model

Yasuhiro Ohshima (Takasaki Advanced Radiation Research Institute, Quantum Beam Science Research Directorate, National Institute for Quantum and Radiological Science and Technology, Takasaki, Japan)

[JSNMS9-2] 2．Development of radiolabeled FF-21101 and its companion diagnosis for solid tumor therapy

Masahiko Tokura^1,2 (1.Development Department, FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan, 2.Pharmaceutical Products Division, FUJIFILM Corporation, Tokyo, Japan)

[JSNMS9-3] 3．Basic research of Radio-theranoscitcs-global and domestic situations-

Tomoya Uehara (Graduate School of Pharmaceutical Sciences, Chiba University)

[JSNMS9-4] 4．Future development of radiotheranostics in clinical practice: world trend and Japan status

Shoko Takano¹, Noritoshi Kobayashi², Yasushi Ichikawa², Hiroshi Uemura³, Motoki Nakamura⁴, Keiichi Horie⁴, Naofumi Yasuda⁴, Kenich Itou⁴, Tomohiro Kaneta⁴, Masaharu Hata¹ (1.Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, 2.Department of Clinical Oncology, Yokohama City University Graduate School of Medicine, 3.Department of Urology & Renal Transplantation, Yokohama City University Medical Center, 4.Department of Radiology, Yokohama City University Graduate School of Medicine)